About
Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalVirginia, DC, DE & Maryland
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
5
As Collaborator
3
Total Enrollment
468
By Phase
PHASE2: 1PHASE1: 2PHASE1/PHASE2: 2PHASE3: 2
By Status
WITHDRAWN: 3UNKNOWN: 3COMPLETED: 1AVAILABLE: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT03014804Collaborator
Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma
PHASE2Withdrawn
Started: Dec 1, 2019 · Completed: Dec 1, 2022
NCT03638765Lead Sponsor
Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer
PHASE1Unknown
24 participants
Started: Nov 30, 2018 · Completed: Dec 31, 2020
NCT01882946Lead Sponsor
Safety and Efficacy Study of DCVax-Direct in Solid Tumors
PHASE1/PHASE2Unknown
60 participants
Started: Jun 30, 2013
NCT00603460Collaborator
DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer
PHASE1/PHASE2Withdrawn
Started: Jan 31, 2012 · Completed: Mar 31, 2013
NCT00683241Collaborator
A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal Cancer
PHASE1Completed
36 participants
Started: Nov 30, 2007 · Completed: Dec 31, 2009
Locations (1)
Headquarters
Bethesda, MD, United States
Map
Loading map...